425: Iron Horse Acquisitions to Merge with Zhong Guo Liang Tou Group, Valuing Combined Entity at $523 Million

Iron Horse Acquisitions Corp. announces a definitive business combination agreement with Rosey Sea Holdings Limited, the parent company of Zhong Guo Liang Tou Group Limited (d/b/a China Food Investment), with an estimated post-transaction enterprise value of $523 million.

Summary

• Iron Horse Acquisitions Corp., a special purpose acquisition company (SPAC), has entered into a definitive business combination agreement (BCA) with Rosey Sea Holdings Limited, the parent company of Zhong Guo Liang Tou Group Limited, also known as China Food Investment (CFI).
• Upon completion of the business combination, Iron Horse will acquire 100% of CFI, making CFI a wholly-owned subsidiary of Iron Horse, which plans to change its name to China Food Investment.
• CFI focuses on producing and selling health and agricultural biotechnology food products through subsidiaries in Hong Kong, PRC, and Mainland China.
• The company aims to promote the consumption of green and healthy food, targeting growth in Asia and internationally.
• The parties anticipate the business combination will close in the first quarter of 2025, with the combined company's shares listed on The Nasdaq Stock Market.
• The transaction is subject to customary closing conditions, including due diligence, regulatory approvals, and Nasdaq approval.
• The combined company is expected to have an estimated post-transaction enterprise value of $523 million.
• Assuming full redemption, the Company will issue to Seller 47,888,000 shares of Common Stock.
• If no eligible shares are redeemed, the number of shares of Common Stock constituting the Consideration will be 40,988,000.

Sentiment

Score: 7

Explanation: The document conveys a positive outlook on the merger, highlighting growth opportunities and the potential for CFI to expand its market presence. The management comments are optimistic, and the overall tone suggests confidence in the success of the business combination.

Positives

• CFI's focus on health and agricultural biotechnology food products aligns with the growing demand for green and healthy food.
• The merger provides CFI with opportunities to expand its reach and product distribution in Asia and internationally.
• Listing on Nasdaq could enhance CFI's visibility and access to capital markets.
• Iron Horse's management expresses excitement about the business combination and CFI's potential to improve the world through its health-focused products.

Risks

• The business combination is subject to closing conditions, including due diligence, regulatory approvals, and Nasdaq approval, which may not be satisfied.
• The announcement or pendency of the business combination could affect CFI's business relationships and operations.
• Changes in applicable laws or regulations could adversely affect the combined company.
• Economic, business, and/or competitive factors could negatively impact Iron Horse or CFI.
• The company may not be able to obtain the listing of the post business combination entity's securities on Nasdaq.

Future Outlook

The combined company expects significant opportunities for CFI to grow its promise of green and healthy food products as it continues expanding in Asia and internationally.

Management Comments

• 'We expect our merger with Iron Horse will bring significant opportunities for CFI to grow its promise of green and healthy food products as we continue expanding,' said Mr. Sean Jiang, Chairman of CFI.
• 'We know Iron Horse set out to find a company who want to better the world in some way, and CFIs focus on health holds the potential to do just that,' said Mr. Sean Jiang, Chairman of CFI.
• 'We are incredibly excited to announce our first deal for what we hope to grow into the Iron Horse family of SPACs,' said Jose A. Bengochea, CEO of Iron Horse Acquisitions.

Industry Context

The announcement reflects the ongoing trend of SPACs merging with companies in high-growth sectors, such as health and wellness, particularly those with a focus on the Asian market.

Comparison to Industry Standards

• The $523 million enterprise value is within the typical range for SPAC mergers, but the ultimate success will depend on CFI's ability to execute its growth strategy and achieve its financial projections.
• Comparable companies in the health food and biotechnology sectors often trade at multiples of revenue or EBITDA, which could be used to assess the valuation of the combined company post-merger.
• The success of the merger will depend on CFI's ability to compete with established players in the Asian health food market and to navigate the regulatory landscape in China.

Stakeholder Impact

• Shareholders of Iron Horse will have the opportunity to participate in the growth of a company focused on the health food sector.
• Employees of CFI may benefit from the increased resources and opportunities resulting from the merger.
• Customers of CFI can expect continued access to green and healthy food products.
• The merger could create value for suppliers and other stakeholders in the CFI ecosystem.

Next Steps

• Completion of due diligence review.
• Obtaining regulatory approvals, including Nasdaq approval.
• Filing and disseminating the Proxy Statement/Prospectus to Iron Horse stockholders.
• Holding the Acquiror Stockholder Meeting to vote on the Transaction Proposals.
• Closing the business combination in the first quarter of 2025.

Key Dates